Davis CB - Search Results

1

Pharmacokinetics of a hematoregulatory peptide (SK&F107647) in healthy male volunteers and in patients with colorectal or pancreatic adenocarcinoma not amenable to standard therapy.

Zia-Amirhosseini P, Harris RZ, Cowley HC, Valle JW, Citerone DR, Boppana VK, Scarffe H, Watson P, Davis CB. Zia-Amirhosseini P, et al. Among authors: davis cb. Pharm Res. 2000 Apr;17(4):385-90. doi: 10.1023/a:1007512617139. Pharm Res. 2000. PMID: 10870980

2

Disposition of growth hormone-releasing peptide (SK&F 110679) in rat and dog following intravenous or subcutaneous administration.

Davis CB, Crysler CS, Boppana VK, Fong KL, Joseph GL, Urbanski JJ, Macia RA, Rhodes GR. Davis CB, et al. Drug Metab Dispos. 1994 Jan-Feb;22(1):90-8. Drug Metab Dispos. 1994. PMID: 8149896 Clinical Trial.

3

Pharmacokinetics and pharmacodynamics of SB-240563, a humanized monoclonal antibody directed to human interleukin-5, in monkeys.

Zia-Amirhosseini P, Minthorn E, Benincosa LJ, Hart TK, Hottenstein CS, Tobia LA, Davis CB. Zia-Amirhosseini P, et al. Among authors: davis cb. J Pharmacol Exp Ther. 1999 Dec;291(3):1060-7. J Pharmacol Exp Ther. 1999. PMID: 10565825

4

Pharmacokinetics and pharmacodynamics of a humanized monoclonal antibody to factor IX in cynomolgus monkeys.

Benincosa LJ, Chow FS, Tobia LP, Kwok DC, Davis CB, Jusko WJ. Benincosa LJ, et al. Among authors: davis cb. J Pharmacol Exp Ther. 2000 Feb;292(2):810-6. J Pharmacol Exp Ther. 2000. PMID: 10640322

5

Impact of erythrocyte Duffy antigen genetic polymorphism on the distribution of GroBeta-T, a novel human CXC chemokine.

Hepburn TW, Tobia LP, Shi W, McIntyre TA, Davis CB. Hepburn TW, et al. Among authors: davis cb. J Pharm Pharm Sci. 2007;10(4):486-95. doi: 10.18433/j33w2m. J Pharm Pharm Sci. 2007. PMID: 18396564 Free article.

6

Pharmacokinetic and pharmacodynamic modeling of humanized anti-factor IX antibody (SB 249417) in humans.

Chow FS, Benincosa LJ, Sheth SB, Wilson D, Davis CB, Minthorn EA, Jusko WJ. Chow FS, et al. Among authors: davis cb. Clin Pharmacol Ther. 2002 Apr;71(4):235-45. doi: 10.1067/mcp.2002.122276. Clin Pharmacol Ther. 2002. PMID: 11956506 Clinical Trial.

7

Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarials.

Davis CB, Bambal R, Moorthy GS, Hugger E, Xiang H, Park BK, Shone AE, O'Neill PM, Ward SA. Davis CB, et al. J Pharm Sci. 2009 Jan;98(1):362-77. doi: 10.1002/jps.21469. J Pharm Sci. 2009. PMID: 18563832

8

Preclinical drug metabolism and pharmacokinetic evaluation of GW844520, a novel anti-malarial mitochondrial electron transport inhibitor.

Xiang H, McSurdy-Freed J, Moorthy GS, Hugger E, Bambal R, Han C, Ferrer S, Gargallo D, Davis CB. Xiang H, et al. Among authors: davis cb. J Pharm Sci. 2006 Dec;95(12):2657-72. doi: 10.1002/jps.20681. J Pharm Sci. 2006. PMID: 16892205

9

Pharmacokinetics and tissue distribution of SB-251353, a novel human CXC chemokine, after intravenous administration to mice.

Hepburn TW, Hart TK, Horton VL, Sellers TS, Tobia LP, Urbanski JJ, Shi W, Davis CB. Hepburn TW, et al. Among authors: davis cb. J Pharmacol Exp Ther. 2001 Sep;298(3):886-93. J Pharmacol Exp Ther. 2001. PMID: 11504781

10

Disposition of metabolically radiolabeled CE9.1--a macaque-human chimeric anti-human CD4 monoclonal antibody--in transgenic mice bearing human CD4.

Davis CB, Garver EM, Kwok DC, Urbanski JJ. Davis CB, et al. Drug Metab Dispos. 1996 Sep;24(9):1032-7. Drug Metab Dispos. 1996. PMID: 8886616

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters